Renal Cell Cancer Update
Newly Approved Agents in HER2-Positive Metastatic Breast Cancer with Dr Mark Pegram
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 1:05:05
- Mais informações
Informações:
Sinopse
Dr Mark Pegram from the Stanford University School of Medicine discusses the latest clinical data on and optimal use of newly approved therapies for HER2-positive metastatic breast cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayHER2MetastaticBC21).
